BIFIDO. Co. Ltd Logo

BIFIDO. Co. Ltd

Biotechnology firm developing human-derived Bifidobacterium for various products.

238200 | KO

Overview

Corporate Details

ISIN(s):
KR7238200000
LEI:
Country:
South Korea
Address:
강원도 홍천군 홍천읍 농공단지길 23-16, 홍천군

Description

BIFIDO Co., Ltd. is a biotechnology company established in 1999 that specializes in the human microbiome. The company's core focus is the research and development of human-derived Bifidobacterium strains for use in functional foods, supplements, and personal care products. BIFIDO operates an integrated platform that covers the entire process from the selection of probiotic and pharmabiotic candidates to the manufacturing of finished goods, marketed under brands like BIFIDOLAB. Its research, supported by extensive scientific papers and patents, targets areas such as immune regulation, cognitive health, and the development of microbiome-based therapeutics for various health conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.1 MB
2025-08-01 00:00
주권관련사채권의취득결정
Korean HTML 35.0 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.1 MB
2025-04-30 00:00
소속부변경
Korean HTML 3.6 KB
2025-03-20 00:00
정기주주총회결과
Korean HTML 17.3 KB
2025-03-12 00:00
감사보고서제출
Korean HTML 25.4 KB
2025-03-12 00:00
사업보고서 (2024.12)
Korean HTML 382.8 KB
2025-03-05 00:00
주주총회소집공고
Korean HTML 127.0 KB
2025-02-26 00:00
주주총회소집결의
Korean HTML 7.5 KB
2025-02-26 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean HTML 10.9 KB
2024-12-20 00:00
[기재정정]신규시설투자등
Korean HTML 12.5 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean HTML 1.0 MB
2024-10-15 00:00
임시주주총회결과
Korean HTML 19.7 KB
2024-10-15 00:00
대표이사변경
Korean HTML 10.6 KB

Automate Your Workflow. Get a real-time feed of all BIFIDO. Co. Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIFIDO. Co. Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIFIDO. Co. Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CG Invites Co., Ltd. Logo
A biopharmaceutical company specializing in digital genomics and personalized medicine.
South Korea
083790
CG Oncology, Inc. Logo
Develops bladder-sparing oncolytic immunotherapies for urologic cancers.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapeutics using proprietary adjuvant platforms.
South Korea
261780
Develops and manufactures veterinary medicines and functional feed additives.
South Korea
052670
Chemical Works of Gedeon Richter Plc Logo
Vertically integrated pharma company focused on women's health and other therapies.
Hungary
RICHT
Chemomab Therapeutics Ltd. Logo
Clinical-stage biotech developing therapeutics for fibro-inflammatory diseases.
United States of America
CMMB
CHINA PHARMA HOLDINGS, INC. Logo
Develops, manufactures, and markets prescription, OTC, and nutritional products.
United States of America
CPHI
China SXT Pharmaceuticals, Inc. Logo
Researches, develops, manufactures, and sells traditional Chinese medicine products.
United States of America
SXTC
ChoA Pharmaceutical Co., LTD. Logo
Develops, manufactures, and sells pharmaceutical products and health supplements.
South Korea
034940
Chong Kun Dang Pharmaceutical Corp. Logo
Develops and manufactures drugs for systemic anti-infectives and metabolic diseases.
South Korea
185750

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.